| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-08-0673 |
| P698 | PubMed publication ID | 18559494 |
| P50 | author | Richard Bergeron | Q73184548 |
| Benjamin K Tsang | Q42713839 | ||
| Douglas A Gray | Q55143473 | ||
| P2093 | author name string | Jan Brun | |
| Emilie J Muller | |||
| Mohammad R Abedini | |||
| P2860 | cites work | Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). | Q40612863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| cisplatin | Q412415 | ||
| protein ubiquitination | Q3547638 | ||
| P304 | page(s) | 4511-4517 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells | |
| P478 | volume | 68 |
| Q26782533 | "Ziziphus jujuba": A red fruit with promising anticancer activities |
| Q36180709 | A delay prior to mitotic entry triggers caspase 8-dependent cell death in p53-deficient Hela and HCT-116 cells |
| Q42874830 | ATM kinase activity modulates cFLIP protein levels: potential interplay between DNA damage signalling and TRAIL-induced apoptosis |
| Q38963051 | Akt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability. |
| Q39791587 | Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein |
| Q34407454 | Cell fate regulation by gelsolin in human gynecologic cancers. |
| Q34089685 | Cellular Responses to Cisplatin‐Induced DNA Damage |
| Q28073246 | Chemoresistance and targeted therapies in ovarian and endometrial cancers |
| Q39725905 | Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIP(L) from degradation by the E3 ligase itch in human melanoma cells |
| Q36832656 | Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance |
| Q34806765 | Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis. |
| Q47636038 | E3 ubiquitin ligases in cancer and implications for therapies |
| Q42321360 | Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin α6β1 in glioblastoma |
| Q26773368 | FLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIP |
| Q53055068 | Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer. |
| Q28397571 | Hyperthermia enhances mapatumumab-induced apoptotic death through ubiquitin-mediated degradation of cellular FLIP(long) in human colon cancer cells |
| Q92827641 | ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells |
| Q39627572 | Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL |
| Q38587869 | Mitochondrial dynamics regulating chemoresistance in gynecological cancers |
| Q39770080 | Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents |
| Q36403630 | Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum |
| Q28397635 | Novel phosphorylation and ubiquitination sites regulate reactive oxygen species-dependent degradation of anti-apoptotic c-FLIP protein |
| Q35359342 | P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. |
| Q36794233 | PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation |
| Q33908881 | Phytochemicals: a multitargeted approach to gynecologic cancer therapy. |
| Q37099682 | Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission |
| Q41579835 | Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome |
| Q92279252 | Regulation of autoimmune disease by the E3 ubiquitin ligase Itch |
| Q34566429 | SB225002 promotes mitotic catastrophe in chemo-sensitive and -resistant ovarian cancer cells independent of p53 status in vitro |
| Q91741787 | SET and MYND domain-containing protein 3 inhibits tumor cell sensitivity to cisplatin |
| Q47289183 | Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest |
| Q35176405 | Synergistic anticancer effect of cisplatin and Chal-24 combination through IAP and c-FLIPL degradation, Ripoptosome formation and autophagy-mediated apoptosis |
| Q42249160 | TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma |
| Q89840958 | Targeting apoptotic caspases in cancer |
| Q38068479 | Targeting c-FLICE-like inhibitory protein (CFLAR) in cancer |
| Q37808833 | Targeting c-FLIP in cancer |
| Q40751673 | Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. |
| Q35762274 | Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy |
| Q38530613 | The E3 ligase Itch in immune regulation and beyond. |
| Q37488549 | The diarylheptanoid hirsutenone sensitizes chemoresistant ovarian cancer cells to cisplatin via modulation of apoptosis-inducing factor and X-linked inhibitor of apoptosis. |
| Q35005636 | The mTORC2 component rictor contributes to cisplatin resistance in human ovarian cancer cells |
| Q39472176 | The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation. |
| Q39727971 | The role of c-FLIP(L) in ovarian cancer: chaperoning tumor cells from immunosurveillance and increasing their invasive potential. |
| Q28391119 | c-FLIP, a master anti-apoptotic regulator |
| Q42872003 | α‐TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway |
Search more.